HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arthur I Sagalowsky Selected Research

Disease Progression

10/2010Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder.
9/2010The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.
9/2009p53 predictive value for pT1-2 N0 disease at radical cystectomy.
5/2009Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer.
1/2009Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer.
11/2007Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
9/2007Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
2/2007Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arthur I Sagalowsky Research Topics

Disease

57Neoplasms (Cancer)
01/2020 - 02/2002
50Carcinoma (Carcinomatosis)
02/2021 - 02/2002
50Urinary Bladder Neoplasms (Bladder Cancer)
01/2016 - 03/2004
18Transitional Cell Carcinoma
03/2008 - 03/2004
12Neoplasm Metastasis (Metastasis)
10/2014 - 03/2004
12Carcinoma in Situ
01/2014 - 11/2005
9Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 10/2006
8Disease Progression
10/2010 - 02/2007
6Prostatic Neoplasms (Prostate Cancer)
05/2010 - 03/2004
5Margins of Excision
01/2020 - 06/2004
5Lymphatic Metastasis
10/2010 - 12/2006
3Kidney Neoplasms (Kidney Cancer)
01/2020 - 03/2013
2Necrosis
01/2016 - 10/2014
2Thrombosis (Thrombus)
09/2015 - 06/2011
2Extranodal Extension
07/2007 - 06/2004
1Non-Muscle Invasive Bladder Neoplasms
11/2016
1Hematuria
04/2015
1Cysts
04/2015
1Nephrolithiasis
04/2015
1Carcinogenesis
06/2014
1Embryonal Carcinoma
05/2014
1Hypoxia (Hypoxemia)
03/2013
1Wilms Tumor (Wilm's Tumor)
10/2012
1Testicular Germ Cell Tumor
09/2012
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
09/2012
1Solitary Kidney
10/2009
1Residual Neoplasm
08/2009
1Obesity
08/2009
1Urologic Neoplasms (Urological Cancer)
11/2008

Drug/Important Bio-Agent (IBA)

16Biomarkers (Surrogate Marker)IBA
11/2016 - 02/2007
7nuclear matrix protein 22IBA
07/2009 - 03/2004
6CyclinsIBA
11/2016 - 12/2006
6SurvivinIBA
11/2009 - 02/2007
5Proteins (Proteins, Gene)FDA Link
08/2014 - 02/2002
5Prostate-Specific Antigen (Semenogelase)IBA
07/2007 - 02/2002
3Alkaline PhosphataseIBA
01/2016 - 10/2014
3Tumor Biomarkers (Tumor Markers)IBA
11/2011 - 09/2006
2Cisplatin (Platino)FDA LinkGeneric
08/2015 - 06/2008
2TOR Serine-Threonine KinasesIBA
11/2014 - 03/2013
2CreatinineIBA
09/2012 - 09/2003
2AndrogensIBA
05/2010 - 02/2010
2Cyclin D1IBA
11/2007 - 12/2006
2DNA (Deoxyribonucleic Acid)IBA
04/2007 - 02/2002
1Immune Checkpoint InhibitorsIBA
01/2020
1Enhancer of Zeste Homolog 2 ProteinIBA
07/2018
1MethyltransferasesIBA
07/2018
1AntibodiesIBA
12/2017
1LipidsIBA
12/2015
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2015
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
09/2015
1Pyruvate KinaseIBA
04/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2015
1Angiopoietin-2IBA
04/2015
1Messenger RNA (mRNA)IBA
08/2014
1Insulin-Like PeptidesIBA
08/2014
1Carrier Proteins (Binding Protein)IBA
08/2014
1CateninsIBA
06/2014
1Cyclin EIBA
04/2014
1Monoclonal AntibodiesIBA
09/2013
1Cyclin-Dependent Kinase Inhibitor p27IBA
09/2013
1Cyclin-Dependent Kinases (cdk Proteins)IBA
09/2013
1AntigensIBA
09/2013
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2013
1Phosphatidylinositols (Phosphatidylinositol)IBA
03/2013
1TensinsIBA
03/2013
1Cell Cycle ProteinsIBA
02/2012
1PlatinumIBA
10/2011
1Sunitinib (Sutent)FDA Link
06/2011
1human ERBB2 proteinIBA
10/2010
1Indicators and Reagents (Reagents)IBA
08/2010
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
05/2010
1Thrombospondin 1IBA
05/2010
1CI 22IBA
01/2010
1GemcitabineFDA Link
06/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2008
1Vinblastine (Vinblastine Sulfate)FDA Link
06/2008
1Methotrexate (Mexate)FDA LinkGeneric
06/2008
1Tumor Viral Antigens (Large T Antigen)IBA
08/2007
1Azacitidine (5 Azacytidine)FDA Link
04/2007

Therapy/Procedure

55Cystectomy
01/2016 - 09/2005
19Lymph Node Excision (Lymph Node Dissection)
05/2014 - 05/2006
18Therapeutics
01/2020 - 09/2006
15Nephroureterectomy
02/2021 - 07/2008
14Adjuvant Chemotherapy
05/2013 - 10/2006
12Drug Therapy (Chemotherapy)
08/2015 - 12/2006
8Nephrectomy
01/2020 - 04/2004
7Neoadjuvant Therapy
12/2020 - 10/2006
5Prostatectomy (Retropubic Prostatectomy)
07/2007 - 02/2002
4Radiofrequency Ablation
01/2016 - 07/2002
3Urinary Diversion (Ileal Conduit)
01/2007 - 04/2002
2Adjuvant Radiotherapy
12/2006 - 10/2006
2Radiotherapy
11/2006 - 03/2004
1Immunotherapy
01/2020
1Length of Stay
01/2020
1Transurethral Resection of Bladder
11/2016
1Orchiectomy (Orchidectomy)
05/2014
1Combined Modality Therapy
12/2012
1Investigational Therapies (Experimental Therapy)
06/2011
1Molecular Targeted Therapy
06/2011
1Conservative Treatment
07/2008